Resonate-2 Study Propels Other Studies using Ibrutnib in Combination Therapy

Resonate-2 Study Propels Other Studies using Ibrutnib in Combination Therapy

User Photo
ASHReport

4 years
544 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Paul Barr, MD of University of Rochester, discusses the use of ibrutinib in combination therapy from Resonate-2 Study at the 58th ASH Annual Meeting in San Diego, CA.
Up Next Autoplay
>